A Post Market Study on the Use of Cormatrix® Cangaroo ECM® (Extracellular Matrix) Envelope (SECURE)

Aziyo Biologics

Status: Completed

Conditions: Cardiovascular Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT02530970

14-PR-1110

Details and patient eligibility

About

The objective of the SECURE Study is to actively gather additional information on the use of the CorMatrix® CanGaroo ECM® Envelope in a post market observational study.

Enrollment: 1,025 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects who have received CorMatrix® CanGaroo ECM® Envelope for an implantable electronic device placement.

Exclusion criteria

Trial design